Cargando…

2399. β-Lactam Therapy for Potential AmpC-Producing Organisms: A Cohort Study and an Updated Systematic Review and Meta-Analysis

BACKGROUND: Certain organisms, including Serratia, Providentia, Acinetobacter, Citrobacter, Enterobacter, and Morganella species (SPACE-M) may possess an inducible broad-spectrum β-lactamase, AmpC, which is not inhibited by most β-lactamase inhibitors. Our objective was to determine whether treating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Matthew P, Lee, Robyn, Cheng, Alexandre P, De L’Étoile-Morel, Samuel, Demir, Koray, Yansouni, Cedric, Harris, Patrick, Mcdonald, Emily, Lee, Todd C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254768/ http://dx.doi.org/10.1093/ofid/ofy210.2052

Ejemplares similares

Beta-Lactam/Beta-Lactamase Inhibitor Therapy for Potential AmpC-Producing Organisms: A Systematic Review and Meta-Analysis
por: Cheng, Matthew P, et al.
Publicado: (2019)

254. Review of Clinical Outcomes in Patients Treated with Beta-lactam vs Non-beta-lactam Therapy for AmpC Producing Bacterial Bloodstream Infections
por: Staicu, Mary L, et al.
Publicado: (2020)

Association between Beta-lactam Antibiotic Resistance and Virulence Factors in AmpC Producing Clinical Strains of P. aeruginosa
por: Dehbashi, Sanaz, et al.
Publicado: (2018)

Relation between Resistance to Antipseudomonal β-Lactams and ampC and mexC Genes of Pseudomonas aeruginosa
por: Rezaei, Fatemeh, et al.
Publicado: (2016)

Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different Pathways, Different Signaling
por: Torrens, Gabriel, et al.
Publicado: (2019)

Induction of AmpC-Mediated β-Lactam Resistance Requires a Single Lytic Transglycosylase in Agrobacterium tumefaciens
por: Figueroa-Cuilan, Wanda M., et al.
Publicado: (2022)

The functional repertoire of AmpR in the AmpC β-lactamase high expression and decreasing β-lactam and aminoglycosides resistance in ESBL Citrobacter freundii
por: Tariq, Falak Naz, et al.
Publicado: (2023)

117. Adjunctive Daptomycin in the Treatment of staphylococcus Aureus Bacteremia
por: Cheng, Matthew P, et al.
Publicado: (2020)

Induction of plasmid-mediated AmpC β-lactamase DHA-1 by piperacillin/tazobactam and other β-lactams in Enterobacteriaceae
por: Akata, Kentaro, et al.
Publicado: (2019)

Multiplication of ampC upon Exposure to a Beta-Lactam Antibiotic Results in a Transferable Transposon in Escherichia coli
por: Darphorn, Tania S., et al.
Publicado: (2021)

646. Adapting the modified Carbapenem Inactivation Method to assess for possible beta-lactamase mediated resistance in Piperacillin-Tazobactam resistant/ Ceftriaxone susceptible Escherichia. coli and Klebsiella pneumoniae
por: Lawandi, Alexander, et al.
Publicado: (2020)

In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways
por: Skoglund, Erik, et al.
Publicado: (2018)

594. A Multi-Centered Study of the Clinical and Molecular Epidemiology of AmpC Cephalosporinase-Producing (AmpC) Enterobacteriaceae (Ent) Infections in Children
por: Medernach, Rachel L, et al.
Publicado: (2019)

Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways”
por: Skoglund, Erik, et al.
Publicado: (2019)

Elevating NagZ Improves Resistance to β-Lactam Antibiotics via Promoting AmpC β-Lactamase in Enterobacter cloacae
por: Yang, Xianggui, et al.
Publicado: (2020)

Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with β-lactams: a prospective multicenter study
por: Mounier, Roman, et al.
Publicado: (2022)

Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales
por: Ávila-Núñez, M., et al.
Publicado: (2023)

Database for the ampC alleles in Acinetobacter baumannii
por: Karah, Nabil, et al.
Publicado: (2017)

2399: Protective immunity to live vaccines among children with solid tumors
por: Garcia Robles, Franchesca, et al.
Publicado: (2018)

2399. Changing Demographics of Infective Endocarditis in South Carolina: An Ecological Study
por: Garrison, Phillip G, et al.
Publicado: (2023)

CTX-M and Plasmid-mediated AmpC-Producing Enterobacteriaceae, Singapore
por: Koh, Tse Hsien, et al.
Publicado: (2004)

2399. Ribotype Diversity of Clostridioides difficile strains obtained during screening tests
por: Munoz-Price, L Silvia, et al.
Publicado: (2019)

Detection of AmpC β-lactamase producing bacteria isolated in neonatal sepsis
por: Salamat, Sonia, et al.
Publicado: (2016)

Phenotypic and Genomic Characterization of AmpC-Producing Klebsiella pneumoniae From Korea
por: Palmieri, Mattia, et al.
Publicado: (2018)

Bloodstream Infections by AmpC-Producing Enterobacterales: Risk Factors and Therapeutic Outcome
por: Pospišil, Mladen, et al.
Publicado: (2023)

Dynamics of faecal shedding of ESBL- or AmpC-producing Escherichia coli on dairy farms
por: Hordijk, Joost, et al.
Publicado: (2019)

Antibiotic Resistance and Virulence Traits in Vancomycin-Resistant Enterococci (VRE) and Extended-Spectrum β-Lactamase/AmpC-producing (ESBL/AmpC) Enterobacteriaceae from Humans and Pets
por: Iseppi, Ramona, et al.
Publicado: (2020)

Clinical Trials Increase Off-Study Drug Use: A Segmented Time-Series Analysis
por: Butler-Laporte, Guillaume, et al.
Publicado: (2020)

Systematic Review of Plasmid AmpC Type Resistances in Escherichia coli and Klebsiella pneumoniae and Preliminary Proposal of a Simplified Screening Method for ampC
por: Rodríguez-Guerrero, Enrique, et al.
Publicado: (2022)

Extended-spectrum beta-lactamases screening agar with AmpC inhibition
por: Al Naiemi, N., et al.
Publicado: (2009)

Fecal Colonization with Extended-Spectrum Beta-Lactamase and AmpC-Producing Escherichia coli
por: Al-Agamy, Mohamed H., et al.
Publicado: (2016)

Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland
por: Kuch, Alicja, et al.
Publicado: (2020)

ESBL/AmpC-Producing Escherichia coli in Wild Boar: Epidemiology and Risk Factors
por: Formenti, Nicoletta, et al.
Publicado: (2021)

Controversies about extended-spectrum and AmpC beta-lactamases.
por: Thomson, K S
Publicado: (2001)

Detection of AmpC β Lactamases in Gram-negative Bacteria
por: Gupta, Gunjan, et al.
Publicado: (2014)

Challenges in detection of AmpC β-lactamases among Enterobacteriaceae
por: Joseph, Noyal Mariya, et al.
Publicado: (2013)

Impact of AmpC Derepression on Fitness and Virulence: the Mechanism or the Pathway?
por: Pérez-Gallego, Marcelo, et al.
Publicado: (2016)

Detection of AmpC β-lactamases in gram-negative bacteria
por: Zhou, Qian, et al.
Publicado: (2022)

Aromatic Diboronic Acids as Effective KPC/AmpC Inhibitors
por: Krajewska, Joanna, et al.
Publicado: (2023)

Structural Investigations of the Inhibition of Escherichia coli AmpC β-Lactamase by Diazabicyclooctanes
por: Lang, Pauline A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_147ed82o0fiaam5hdk7v2g2hq3